Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?
批准号:
7264712
负责人:
Suzanne Walker
金额:
$42.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2011-03-31
关键词:
AddressAnabolismAnimal ModelAnti-Infective AgentsAntibiotic ResistanceAntimicrobial susceptibilityBacteriaBacterial InfectionsBehaviorBiochemistryBiological AssayBiological ModelsBuffersCell WallCell surfaceChemicalsCommunitiesConditionEnterococcus faecalisEnzymatic BiochemistryEnzymesFoundationsGenesGeneticGoalsGram-Positive BacteriaIn VitroIndividualInfectionInterventionIonsKineticsLengthListeria monocytogenesMetabolic PathwayMetalsMethodsMicrobial PhysiologyMolecularMonitorNADPOrganismOrthologous GenePathogenesisPathway interactionsPlayPolymersProductionProtein OverexpressionPublic HealthRangeReactionReportingResearchResearch PersonnelResistanceRoleScreening procedureStaphylococcus aureusStaphylococcus epidermidisStreptococcus pneumoniaeSubstrate SpecificitySurfaceTeichoic AcidsTestingTherapeuticTherapeutic InterventionVancomycin-resistant S. aureusVirulenceVirulence FactorsVirulentWalkersWorkanalogantimicrobialbasechemotherapycytidine diphosphate ribitolhigh throughput screeninginhibitor/antagonistinorganic phosphateinterestmicroorganismpathogenpathogenic bacteriapolyglycerolpolyribitol phosphateprogramsreconstitutionresearch studyribitol-5-phosphateribulosetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Antibiotic resistance poses a significant threat to public health. The emergence of several vancomycin-resistant Staphylococcus aureus strains in recent years is particularly frightening because S. aureus is a highly virulent pathogen. There is a pressing need for new strategies to treat resistant Gram positive infections. The long term goal of the proposed research is to evaluate a largely unexplored metabolic pathway as a target for antimicrobial chemotherapy. This pathway, found in many pathogenic Gram positive bacteria, involves the biosynthesis of wall teichoic acids (WTAs). Wall teichoic acids are surface-associated anionic polymers. In some organisms these polymers are essential for survival; in S. aureus, they function as virulence factors that play a critical role in the establishment and spread of infection. Therefore, strategies to disrupt wall teichoic acid biosynthesis may have therapeutic utility. The specific aims of the research include: I) Elucidating the enzymology of key WTA biosynthetic enzymes from B. subtilis, the major Gram positive model organism. Chemical methods, approaches, and tools will be developed to study TagA, TagB, and TagF, three enzymes involved in WTA biosynthesis in B. subtilis 168. Unusual features of these enzymes will be explored. II) Characterizing the pathway for WTA biosynthesis in S. aureus using a combination of genetics and in vitro biochemistry. The approaches developed to study the 6. subtilis enzymes will be applied to characterize the S. aureus enzymes. Unresolved questions about WTA biosynthesis in S. aureus will be addressed. III) Establishing a multi-target high throughput screen for wall teichoic acid biosynthesis. An in vitro screen for several successive enzymes involved in WTA biosynthesis will be established and implemented, and the hits will be evaluated against B. subtilis and S. aureus targets. The experiments outlined in this proposal will lay the groundwork for evaluating wall teichoic acid biosynthesis as a target for antimicrobial chemotherapy and will provide fundamental information about the WTA pathway in S. aureus and about some of the more interesting WTA enzymes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploiting membrane targets to overcome antibiotic resistance
-
批准号:10699952
-
项目类别:
-
资助金额:$251.52万
-
财政年份:2022
-
负责人:Suzanne Walker
-
依托单位:
Administrative Core
-
批准号:10699953
-
项目类别:
-
资助金额:$13.13万
-
财政年份:2022
-
负责人:Suzanne Walker
-
依托单位:
Project 2: Targeting Gram-positive Cell Envelope Assembly
-
批准号:10699955
-
项目类别:
-
资助金额:$73.23万
-
财政年份:2022
-
负责人:Suzanne Walker
-
依托单位:
Subproject 1 Compounds and Strategies for Treating MRSA and VRE
-
批准号:9151286
-
项目类别:
-
资助金额:$54.84万
-
财政年份:2016
-
负责人:Suzanne Walker
-
依托单位:
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics
-
批准号:8633483
-
项目类别:
-
资助金额:$3.88万
-
财政年份:2013
-
负责人:Suzanne Walker
-
依托单位:
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics
-
批准号:8411474
-
项目类别:
-
资助金额:$5.69万
-
财政年份:2013
-
负责人:Suzanne Walker
-
依托单位:
Enabling Biotechnologies to Generate Novel Phosphoglycolipid Antibiotics
-
批准号:8815348
-
项目类别:
-
资助金额:$3.88万
-
财政年份:2013
-
负责人:Suzanne Walker
-
依托单位:
Defining OGT's Essential Functions to Guide Therapeutic Approaches
-
批准号:10316265
-
项目类别:
-
资助金额:$44.31万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Structure, Function and Inhibition of Human O-GlcNAc Transferase
-
批准号:8234495
-
项目类别:
-
资助金额:$53.03万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Compound and Strategies for Treating MRSA and VRE
-
批准号:8376868
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Defining OGT's Essential Functions to Guide Therapeutic Approaches - EQUIPMENT SUPPLEMENT
-
批准号:10386477
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Structure, Function and Inhibition of Human O-GlcNAc Transferase
-
批准号:9113808
-
项目类别:
-
资助金额:$42.94万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Structure, Function and Inhibition of Human O-GlcNAc Transferase
-
批准号:9025947
-
项目类别:
-
资助金额:$2.75万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Defining OGT's Essential Functions to Guide Therapeutic Approaches
-
批准号:10728402
-
项目类别:
-
资助金额:$7.77万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Defining OGT's Essential Functions to Guide Therapeutic Approaches
-
批准号:10524029
-
项目类别:
-
资助金额:$44.04万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Structure, Function and Inhibition of Human O-GlcNAc Transferase
-
批准号:8796187
-
项目类别:
-
资助金额:$51.75万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Structure, Function and Inhibition of Human O-GlcNAc Transferase
-
批准号:8415976
-
项目类别:
-
资助金额:$49.87万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Structure, Function and Inhibition of Human O-GlcNAc Transferase
-
批准号:9248380
-
项目类别:
-
资助金额:$42.94万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Diversity Supplement: Defining OGT's Essential Functions to Guide Therapeutic Approaches
-
批准号:10472096
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2012
-
负责人:Suzanne Walker
-
依托单位:
Compound and Strategies for Treating MRSA and VRE
-
批准号:8202904
-
项目类别:
-
资助金额:$41.41万
-
财政年份:2011
-
负责人:Suzanne Walker
-
依托单位:
海外基金